Canada cannabis sales increased 94% over the year and 6% sequentially to CA$244.9 million in August.
According to Statistics Canada, the growth can be attributed to the expansion of the retail footprint across provinces, including British Columbia and especially Ontario.
Ontario sales contributed with CA$66.9 million in sales, which accounted for 11%, compared to 2-5% other major provinces contributed.
Other drivers of growth are the success in value-priced flower and the launch of next-generation products, particularly vapes, New Cannabis Ventures reports.
Moreover, cannabis sales in Ontario increased by more than 66% from CA$40.2 million reported in April.
At the time, Analyst Pablo Zuanic named Aphria Inc. APHA as Cantor's top pick among Canadian licensed companies and Canopy Growth Corp. CGC WEED a "close second."
Meantime, August was the first time for the market to fail achieving year-over-year growth of over 100%.
The data analytics provider Hifyre IQ, which projected sales of $255 million, anticipates September growth to stand at 7% above its August forecast.
In addition, in August, product categories marginally shifted compared to September. According to the same source, pre-rolls increased from 18% to 19%, while flower declined from 54% to 53%.
Courtesy image
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!